By Professor Bruce James Brew

Journal articles

Guillemin GJ; Rahman A; Ting K; Cullen KM; Braidy N; Chung RS; Wu W; Brew BJ, 2010, 'INVOLVEMENT OF THE KYNURENINE PATHWAY IN ALZHEIMER'S DISEASE', JOURNAL OF NEUROCHEMISTRY, 115, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281812600096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhou L; Diefenbach E; Crossett B; Tran SL; Ng T; Rizos H; Rua R; Wang B; Kapur A; Gandhi K; Brew BJ; Saksena NK, 2010, 'First evidence of overlaps between HIV-associated dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia', Molecular Neurodegeneration, 5, http://dx.doi.org/10.1186/1750-1326-5-27

Brew BJ; Cysique LA, 2010, 'Editorial: Alzheimer disease and HIV: A tangled story', Neurology, 75, pp. 105 - 106, http://dx.doi.org/10.1212/WNL.0b013e3181e7b6a4

Hagberg L; Cinque P; Gisslen M; Brew BJ; Spudich S; Bestetti A; Price RW; Fuchs D, 2010, 'Cerebrospinal fluid neopterin: An informative biomarker of central nervous system immune activation in HIV-1 infection', AIDS Research and Therapy, 7, http://dx.doi.org/10.1186/1742-6405-7-15

McArthur JC; Brew BJ, 2010, 'HIV-associated neurocognitive disorders: Is there a hidden epidemic?', AIDS, 24, pp. 1367 - 1370, http://dx.doi.org/10.1097/QAD.0b013e3283391d56

Brew BJ, 2010, 'HIV and the Acquired Immunodeficiency Syndrome: An Overview of Neurological Complications', , pp. 340 - 341, http://dx.doi.org/10.1002/9781444317008.ch92

Brew BJ, 2010, 'HIV-Associated Cerebral Opportunistic Infections', , pp. 356 - 359, http://dx.doi.org/10.1002/9781444317008.ch97

Brew BJ, 2010, 'HIV-Associated Lymphoma: Neurologic Complications', , pp. 360 - 361, http://dx.doi.org/10.1002/9781444317008.ch98

Cherry CL; Affandi JS; Brew BJ; Creighton J; Djauzi S; Hooker DJ; Imran D; Kamarulzaman A; Kamerman P; McArthur JC; Moore RD; Price P; Smyth K; Tan IL; Vanar S; Wadley A; Wesselingh SL; Yunihastuti E, 2010, 'Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV', Neurology, 74, pp. 1538 - 1542, http://dx.doi.org/10.1212/WNL.0b013e3181dd436d

Brew BJ, 2010, 'Neurodegeneration in the HAART era', RETROVIROLOGY, 7, pp. 3 - 3, http://dx.doi.org/10.1186/1742-4690-7-S1-I7

Brew BJ, 2010, 'Benefit or toxicity from neurologically targeted antiretroviral therapy?', Clinical Infectious Diseases, 50, pp. 930 - 932, http://dx.doi.org/10.1086/650744

Lifson A; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Krum E; Nelson R; Pedersen C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J, 2010, 'Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials', HIV Clinical Trials, 11, pp. 205 - 219, http://dx.doi.org/10.1310/hct1104-205

Davies NWS; Guillemin G; Brew BJ, 2010, 'Tryptophan, neurodegeneration and HIV-associated neurocognitive disorder', International Journal of Tryptophan Research, 3, pp. 121 - 140, http://dx.doi.org/10.4137/ijtr.s4321

Lim CK; Brew BJ; Sundaram G; Guillemin GJ, 2010, 'Understanding the roles of the kynurenine pathway in multiple sclerosis progression', International Journal of Tryptophan Research, 3, pp. 157 - 167, http://dx.doi.org/10.4137/ijtr.s4294

Cherry C; Brew B; Downs C; Gregorio‐King C; Cooke I; Rennie G; Goodchild C, 2010, '270 FLUPIRTINE AS AN ADJUNCT TO OPIOID ANALGESIA IN HIV NEUROPATHY PAIN', European Journal of Pain Supplements, 4, pp. 78 - 78, http://dx.doi.org/10.1016/s1754-3207(10)70275-3

Ng K; Kumar K; Brew B; Burke D, 2010, '4. The electrophysiological features of HIV peripheral neuropathy', Clinical Neurophysiology, 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.024

Brew B, 2010, 'A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease', Neurobehavioral HIV Medicine, pp. 59 - 59, http://dx.doi.org/10.2147/nbhiv.s7167

Lee M; Ting KK; Adams S; Brew BJ; Chung R; Guillemin GJ, 2010, 'Characterisation of the expression of NMDA receptors in human astrocytes', PLoS One, 5, pp. e14123

Guillemin GJ; Rahman A; Ting KK; Cullen K; Braidy N; Chung R; Wu W; Brew BJ, 2010, 'P4‐002: Involvement of the Kynurenine Pathway in Alzheimer's Disease', Alzheimer's & Dementia, 6, http://dx.doi.org/10.1016/j.jalz.2010.08.063

Brew BJ; Davies NWS; Cinque P; Clifford D; Nath A, 2010, 'Progressive multifocal leukoencephalopathy and other forms of JC virus disease', Nature Reviews Neuroscience, 6, pp. 667 - 679

Dunbar M; Murray JM; Cysique LA; Brew BJ; Jeyakumar V, 2010, 'Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment', European Journal of Operational Research, 206, pp. 470 - 478, http://www.sciencedirect.com/science/article/B6VCT-4YM7FH3-4/2/a3b9972e52fd64b1f7b5439ecdb15184

Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H, 2009, 'Amyloid and tau cerebrospinal fluid biomarkers in HIV infection', BMC Neurology, 9, http://dx.doi.org/10.1186/1471-2377-9-63

Joseph J; Clifford D; Douglas SD; Fox H; Gendelman HE; Gonzalez-Scarano F; Grant I; Major E; McArthur J, 2009, 'Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 4, pp. 283 - 297, http://dx.doi.org/10.1007/s11481-009-9159-1

Churchill MJ; Wesselingh SL; Cowley D; Pardo CA; McArthur JC; Brew BJ; Gorry PR, 2009, 'Extensive astrocyte infection is prominent in human immunodeficiency virus - associated dementia', Annals of Neurology, 66, pp. 253 - 258, http://dx.doi.org/10.1002/ana.21697

Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain (Journal of Virology (2009) 83, 11, (5430-5441))', Journal of Virology, 83, pp. 7794, http://dx.doi.org/10.1128/JVI.01082-09

Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sheffief S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain', Journal of Virology, 83, pp. 5430 - 5441, http://dx.doi.org/10.1128/JVI.02648-08

Tan IL; Brew BJ, 2009, 'Possible JCV granular cell neuronopathy in a patient with HIV infection', Neurology, 73, pp. 1598 - 1599, http://dx.doi.org/10.1212/WNL.0b013e3181c0d6cb

Brew BJ; Gisslen M; Pemberton L; Cinque P; Hagberg L; Price RW; Blennow K; Spudich S, 2009, '110. CSF t-tau, p-tau and Amyloid Beta 1-42 in HIV Infection', Journal of Clinical Neuroscience, 16, pp. 464 - 464, http://dx.doi.org/10.1016/j.jocn.2008.07.009

Brew B; Tisch S, 2009, '20. Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', Journal of Clinical Neuroscience, 16, pp. 1531 - 1531, http://dx.doi.org/10.1016/j.jocn.2009.07.045

Sher L; Cramer D; Grinyer J; Hall BM; Brayman K; Mirmira R, 2009, 'Editorial introductions', Current Opinion in Organ Transplantation, 14

Ting KK; Brew BJ; Guillemin GJ, 2009, 'Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease', Journal of Neuroinflammation, 6, pp. 1 - 13

Braidy N; Grant RS; Brew BJ; Adams S; Jayasena T; Guillemin GJ, 2009, 'Effects of Kynurenine Pathway Metabolites on Intracellular NAD+ Synthesis and Cell Death in Human Primary Astrocytes and Neurons', International Journal of Tryptophan Research : IJTR, 2, pp. 61 - 69

Brew BJ, 2009, 'HIV, the brain, children, HAART and `neuro-HAART`: A complex mix', AIDS, 23, pp. 1909 - 1910

Braidy N; Grant RS; Adams S; Brew BJ; Guillemin GJ, 2009, 'Mechanism for quinolinic acid cytotoxicity in human astrocytes & neurons', Neurotoxicity Research, 16, pp. 77 - 86

Brew BJ; Crowe S; Landay A; Cysique LA; Guillemin GJ, 2009, 'Neurodegeneration and ageing in the HAART era', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 4, pp. 163 - 174

Cysique LA; Brew BJ, 2009, 'Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: A review', Neuropsychology Review, 19, pp. 169 - 185

Guillemin GJ; Rahman A; Cullen KM; Ting KK; Braidy N; Brew BJ, 2009, 'P3‐195: Involvement of the kynurenine pathway in Alzheimer's disease', Alzheimer's & Dementia, 5, http://dx.doi.org/10.1016/j.jalz.2009.04.1069

Tisch S; Brew BJ, 2009, 'Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', Neurology, 73, pp. 401 - 403

Rahman A; Ting K; Cullen KM; Braidy N; Brew BJ; Guillemin GJ, 2009, 'The excitotoxin quinolinic acid induces tau phosphorylation in human neurons', PLoS One, 4, pp. e6344 -1 - 15

Maruff P; Thomas E; Cysique LA; Brew BJ; Collie A; Snyder P; Pietrzak R, 2009, 'Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex', Archives of Clinical Neuropsychology, 24, pp. 165 - 178

Maneglier B; Guillemin G; Clayette P; Brew B; Rogez-Kreuz C; Advenier C; Spreux-Varoquaux O, 2008, 'Involvement of tryptophan catabolism during HIV-1 infection in primary culture of human monocytes-derived macrophages', FUNDAMENTAL & CLINICAL PHARMACOLOGY, 22, pp. 99 - 99, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256760500481&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Batmanian JJ; Lam M; Matthews C; Finckh A; Duffy M; Wright R; Brew BJ; Markus R, 2008, 'Reply', Medical Journal of Australia, 188, pp. 489 - 490, http://dx.doi.org/10.5694/j.1326-5377.2008.tb01732.x

Cherry C; Duncan A; Mackie K; Wesselingh S; Brew BJ, 2008, 'A Report on the Effect of Commencing Enfuvirtide on Peripheral Neuropathy', AIDS Research and Human Retroviruses, 24, pp. 1027 - 1030

Brew BJ; Letendre S, 2008, 'Biomarkers of HIV related central nervous system disease', International Review of Psychiatry, 20, pp. 73 - 88, http://dx.doi.org/10.1080/09540260701878082

Owe-Young R; Webster N; Mukhtar M; Pomerantz R; Smythe GA; Walker DW; Armati P; Crowe SM; Brew BJ, 2008, 'Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicity', Journal of Neurochemistry, 105, pp. 1346 - 1357, http://dx.doi.org/10.1111/j.1471-4159.2008.05241.x

Wright E; Nunn M; Joseph J; Robertson K; Lal L; Brew BJ, 2008, 'NeuroAIDS in the Asia Pacific Region', Journal of Neurovirology, 14, pp. 465 - 473

Wright E; Brew BJ; Arayawichanont A; Robertson K; Samintharapanya K; Kongsaengdao S; Lim M; Vonthanak S; Lal L; Sarim C; Huffam SE; Li P; Imran D; Lewis J; Lun W; Kamarulzaman A; Tau G; Ali ST; Kishore K; Bain MA; Dwyer R; McCormack G; Hellard M; Cherry C; McArthur J; Wesselingh S, 2008, 'Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region', Neurology, 71, pp. 50 - 56

Wright E; Brew BJ; Wesselingh S, 2008, 'Pathogenesis and diagnosis of viral infections of the nervous system', Neurologic Clinics, 26, pp. 617 - 617

Wright E; Brew BJ; Lal L; Ali ST; Arayawichanont A; Imran D; Kamarulzaman A; Kongsaengdao S; Kruy L; Merati T; Samintharapanya K; Sarim C; Tau G; Thangsing C; Vin-Samnang C; Wesselingh S, 2008, 'Response to Birbeck et al', Epilepsia, 49, pp. 541 - 543

Maneglier B; Guillemin GJ; Clayette P; Rogez-Kreuz C; Brew BJ; Dormont D; Advenier C; Therond P; Spreux-Varoquaux O, 2008, 'Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT1A receptors', British Journal of Pharmacology, 154, pp. 174 - 182, http://dx.doi.org/10.1038/bjp.2008.80

Back to profile page